[Form 4] Molina Healthcare, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Molina Healthcare (MOH) – Form 4 insider filing: Director Richard C. Zoretic received 180 shares of common stock on 01 July 2025 under the company’s 2025 Equity Incentive Plan. The quarterly grant is part of an annual equity award valued at $220,000; one-quarter ($55,000) is issued each quarter using the period’s closing price. At a closing price of $306.29, the quarterly amount translated into 180 shares. Following the transaction, Zoretic, through his revocable living trust, beneficially owns 7,345 shares of MOH. No derivative securities were involved, and the shares are held indirectly by the trust. This routine, compensation-related issuance modestly increases insider ownership and does not materially affect the company’s share count or capital structure.

Positive

• Alignment of interests: Quarterly equity grant increases director’s skin in the game, reinforcing governance alignment.

Negative

• None.

Insights

Senior Securities Analyst

TL;DR – Routine director equity grant; negligible impact on valuation or float.

The Form 4 discloses a standard quarterly equity award to Director Richard C. Zoretic: 180 shares worth $55k (based on the $306.29 close). Post-grant ownership rises to 7,345 shares, a <1 bps addition relative to MOH’s ~58 m shares outstanding, implying immaterial dilution. Such awards align director interests with shareholders and signal continued board engagement but carry no directional signal on fundamentals. I classify this as neutral/not impactful for investment theses.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZORETIC RICHARD C

(Last) (First) (Middle)

2180 HARVARD STREET

SUITE 400

(Street)

SACRAMENTO CA 95815

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2025		A(1)		180(2)	A	$306.29(3)	7,345	I	Held by trust(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2025 was $306.29, which resulted in a grant of 180 shares.

3. Represents the closing price of the Issuer's common stock on July 1, 2025.

4. All shares held by the Richard Charles Zoretic Revocable Living Trust.

Remarks:

	Jeff D. Barlow, by power of attorney for Richard C. Zoretic	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Molina Healthcare (MOH) shares did Director Richard C. Zoretic acquire?

He received 180 shares on 01 July 2025 as part of his quarterly equity award.

What was the grant price for the MOH shares?

The shares were valued at the 01 July 2025 closing price of $306.29.

What is the total annual equity compensation for Molina Healthcare directors?

Each director receives equity worth $220,000 annually, issued in four quarterly installments of $55,000.

How many MOH shares does Richard C. Zoretic now beneficially own?

After the transaction, he beneficially owns 7,345 shares, held via his revocable living trust.

Does this Form 4 signal insider buying or selling pressure on MOH stock?

No; it reflects a routine, compensation-related grant, not discretionary insider buying or selling.